Search - tctmd.com

Displaying 221 - 240 of 418

Sort: Relevancy | Date

Presentation TCT 2017

Real World Evidence: Industry view

Presenter: Daniel A Canos, Kazuhiro Sase, Larry L. Wood

October 30, 2017

Presentation TCT 2017

Real World Evidence: Academic view

Presenter: Daniel A Canos, Kazuhiro Sase, Mitchell W. Krucoff

October 30, 2017

Presentation TCT 2017

Real World Evidence: PMDA view

Presenter: Daniel A Canos, Kazuhiro Sase, Haruki Shirato

October 30, 2017

Presentation TCT 2017

Real World Evidence and The National Evaluation System for health Technologies (NEST): FDA View

Presenter: Daniel A Canos, Kazuhiro Sase

October 30, 2017

Presentation TCT 2017

Japan-USA Endovascular AV Fistula

Presenter: Robert Thatcher, Hiroyoshi Yokoi, Prabir Roy-Chaudhury

October 30, 2017

Presentation TCT 2017

Japan-USA Orbital Atherectomy for Calcific Coronary Lesions

Presenter: Robert Thatcher, Hiroyoshi Yokoi, Brad Martinsen

October 30, 2017

Presentation TCT 2017

Japan-USA Coronary Stent Innovation: EPC Capture

Presenter: Robert Thatcher, Hiroyoshi Yokoi, Stephen Rowland

October 30, 2017

Presentation TCT 2017

Industry Perspective on HBD

Presenter: Fumiaki Ikeno, Yuka Suzuki, Neal Fearnot

October 30, 2017

Presentation TCT 2017

Academic Perspective on HBD

Presenter: Fumiaki Ikeno, Yuka Suzuki, Shigeru Saito

October 30, 2017

Presentation TCT 2017

MHLW/PMDA Perspectives on HBD: Past, Present, and Future

Presenter: Fumiaki Ikeno, Yuka Suzuki, Kiyohito Nakai

October 30, 2017

Presentation TCT 2017

FDA Perspectives on HBD: Past, Present, and Future

Presenter: Fumiaki Ikeno, Yuka Suzuki, Bram D. Zuckerman

October 30, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Opinion Editor's Corner TCT 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Shelley Wood

November 07, 2016

News Conference News TCT 2016

No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low

Shelley Wood

November 07, 2016

News Industry News TCT 2016

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

November 02, 2016

News Conference News TCT 2016

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Yael L. Maxwell

November 02, 2016

News Conference News TCT 2016

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

Todd Neale

November 01, 2016

News Industry News TCT 2016

Long-Term Study Results Show that PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke

November 01, 2016

News Conference News TCT 2016

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

Michael O'Riordan

November 01, 2016

News Conference News TCT 2016

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

Yael L. Maxwell

November 01, 2016

Advertisement

Real World Evidence: Industry view

Real World Evidence: Academic view

Real World Evidence: PMDA view

Real World Evidence and The National Evaluation System for health Technologies (NEST): FDA View

Japan-USA Endovascular AV Fistula

Japan-USA Orbital Atherectomy for Calcific Coronary Lesions

Japan-USA Coronary Stent Innovation: EPC Capture

Industry Perspective on HBD

Academic Perspective on HBD

MHLW/PMDA Perspectives on HBD: Past, Present, and Future

FDA Perspectives on HBD: Past, Present, and Future

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

Long-Term Study Results Show that PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content